DOI 10.1016/j.resuscitation.2026.110982
Effects of mild hypercapnia on myocardial injury among ST-elevation myocardial infarction patients after out-of-hospital cardiac arrest: a exploratory post-hoc study of the TAME trial.
Аннотация
BACKGROUND
Targeting mild hypercapnia reduced myocardial injury in a single-centre cohort of STelevation myocardial infarction (STEMI) patients from the multinational Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) trial. We examined the effect of mild hypercapnia on myocardial injury and outcomes in all acute myocardial infarction (AMI) patients of the TAME trial.
METHODS
Post-hoc exploratory study of the TAME trial that compared the effect of targeted mild hypercapnia or normocapnia in comatose adults after out-of-hospital cardiac arrest (OHCA). The primary outcome was myocardial injury assessed by peak high-sensitivity cardiac troponin T (hs-cTnT) or troponin I (cTnI) levels during hospitalisation in STEMI and successfully percutaneous coronary intervention (PCI) treated STEMI patients. Secondary outcomes included lactate clearance, in-hospital mortality, and neurological outcome at six months.
RESULTS
We studied 810 of 1700 TAME patients (49%) that were diagnosed with AMI. Of these, 593 had STEMI (73%), with 287 patients (48%) in the mild hypercapnia group and 306 (52%) in the normocapnia group. Troponin levels were available for 562 STEMI patients (95%). There was no difference in troponin level (ratio of geometric means (95% (CI) (mild hypercapnia/normocapnia) cTnI 1.18 (0.79-1.77), hs-cTnT 1.20 (0.88-1.63)) or lactate clearance over the first 24 h according to treatment allocation. In-hospital mortality in STEMI patients was 112 of 287 (39%) vs. 124 of 306 (40.5%) patients in the mild hypercapnia group vs. normocapnia group, respectively (Relative Risk 0.97, 95% CI, 0.82-1.14). At six months, 129 of 267 (44.3%) vs. 125 of 282 (48.5%) patients in the mild hypercapnia group vs normocapnia group had a favourable neurological outcome (Relative Risk 1.09, 95% CI, 0.92-1.29). For successful PCI STEMI patients there were no significant differences in any outcomes according to treatment allocation.
CONCLUSION
Among STEMI patients of the TAME trial, myocardial injury, in-hospital mortality, and neurological outcome at six months were not modified by allocation to targeted mild hypercapnia.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.